Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (5,796)	$ (65,101)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	6,483	2,463
Amortization of operating lease right-of-use assets	582	345
Loss on sale and impairment of long-lived assets	70	68
Loss (gain) on remeasurement of private warrant liability	(10,189)	15,910
Loss (gain) on remeasurement of contingent consideration	3,205	(355)
Loss (gain) on remeasurement of earnout liability	(11,179)	18,770
Stock-based compensation	5,854	16,835
Amortization of investment premium/accretion of discount, net	566
Net realized losses on investments	68
Interest expense (non-cash)	1,046	311
Other	64
Other		(225)
Change in operating assets and liabilities, net of acquisitions and divestitures
Accounts receivable	(1,296)	(846)
Reinsurance balance due	(11,323)
Prepaid expenses and other current assets	(6,749)	441
Accounts payable	1,051	(8,090)
Accrued expenses and other current liabilities	(3,145)	2,625
Losses and loss adjustment expense reserves	17,659
Other insurance liabilities, current	3,025
Deferred revenue	(2,228)	(1,362)
Refundable customer deposits	1,412	(837)
Contingent consideration - business combination		(1,663)
Long-term insurance commissions receivable	(1,540)	(1,383)
Operating lease liabilities, non-current	(235)	(354)
Other	(696)	(487)
Net cash used in operating activities	(13,291)	(22,935)
Cash flows from investing activities:
Purchases of property and equipment	(1,167)	(34)
Capitalized internal use software development costs	(1,574)	(798)
Purchases of short-term and long-term investments	(8,835)
Maturities, sales of short-term and long-term investments	8,449
Non-refundable deposit for acquisition	(4,950)
Acquisitions, net of cash acquired		(22,882)
Net cash used in investing activities	(8,077)	(23,714)
Cash flows from financing activities:
Repayments of principal and related fees	(150)	(150)
Proceeds from exercises of warrants		89,771
Proceeds from exercises of stock options	473	355
Income tax withholdings	(712)	(16,997)
Settlement of contingent consideration related to a business acquisition		(400)
Net cash (used) provided by financing activities	(389)	72,579
Net change in cash, cash equivalents, and restricted cash	(21,757)	25,930
Cash, cash equivalents, and restricted cash, beginning of period	324,792	207,453
Cash, cash equivalents, and restricted cash end of period	303,035	233,383
Supplemental disclosures
Cash paid for interest	$ 1,587	903
Non-cash consideration for acquisitions		2,906
Earnout liability		25,815
Proceeds receivable from exercises of warrants		$ 3,237